NEOADJUVANT THERAPY-INDUCED SARCOPENIA IS ASSOCIATED WITH DECREASED OVERALL SURVIVAL IN PANCREATIC DUCTAL ADENOCARCINOMA

被引：0
|
作者：
Sell, Naomi M.
Fernandez-del Castillo, Carlos
Ferrone, Cristina R.
Lillemoe, Keith
Hank, Thomas P.
Weekes, Colin D.
Torriani, Martin
Buckless, Colleen G.
Silver, Julie K.
Fintelmann, Florian J.
Qadan, Motaz
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
795
引用
收藏
页码：S1527 / S1528
页数：2
相关论文
共 50 条
  • [41] Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis
    Zhao, Qing
    Rashid, Asif
    Gong, Yun
    Katz, Matthew H.
    Lee, Jeffrey E.
    Wolf, Robert
    Balachandran, Aparna
    Varadhachary, Gauri R.
    Pisters, Peter W.
    Wang, Hua
    Gomez, Henry F.
    Abbruzzese, James L.
    Fleming, Jason B.
    Wang, Huamin
    [J]. ANNALS OF DIAGNOSTIC PATHOLOGY, 2012, 16 (01) : 29 - 37
  • [42] Does neoadjuvant therapy improve survival in pancreatic adenocarcinoma?
    Chopra, Asmita
    Paniccia, Alessandro
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (05) : 728 - 730
  • [43] Neoadjuvant Chemotherapy and Radiation Improves Recurrence-free and Overall Survival in Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kelley, Jesse K.
    Kolbeinsson, Hordur
    Chandana, Sreenivasa
    Eastburg, Benjamin
    Frisch, Austin
    Parker, Jessica
    Wright, G. Paul
    Assifi, M. Mura
    Chung, Mathew
    [J]. AMERICAN SURGEON, 2024,
  • [44] MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma
    Preis, Meir
    Gardner, Timothy B.
    Gordon, Stuart R.
    Pipas, J. Marc
    Mackenzie, Todd A.
    Klein, Erin E.
    Longnecker, Daniel S.
    Gutmann, Edward J.
    Sempere, Lorenzo F.
    Korc, Murray
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (17) : 5812 - 5821
  • [45] Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation
    Estrella, Jeannelyn S.
    Rashid, Asif
    Fleming, Jason B.
    Katz, Matthew H.
    Lee, Jeffrey E.
    Wolf, Robert A.
    Varadhachary, Gauri R.
    Pisters, Peter W. T.
    Abdalla, Eddie K.
    Vauthey, Jean-Nicolas
    Wang, Hua
    Gomez, Henry F.
    Evans, Douglas B.
    Abbruzzese, James L.
    Wang, Huamin
    [J]. CANCER, 2012, 118 (01) : 268 - 277
  • [46] High Neuropilin 1 Expression Was Associated With Angiogenesis and Poor Overall Survival in Resected Pancreatic Ductal Adenocarcinoma
    Ben, Qiwen
    Zheng, Jianming
    Fei, Jian
    An, Wei
    Li, Ping
    Li, Zhaoshen
    Yuan, Yaozong
    [J]. PANCREAS, 2014, 43 (05) : 744 - 749
  • [47] The Role of Radiation Therapy in Pancreatic Ductal Adenocarcinoma in the Neoadjuvant and Adjuvant Settings
    Franke, Aaron J.
    Rosati, Lauren M.
    Pawlik, Timothy M.
    Kumar, Rachit
    Herman, Joseph M.
    [J]. SEMINARS IN ONCOLOGY, 2015, 42 (01) : 144 - 162
  • [48] Neoadjuvant Therapy of Pancreatic Ductal Adenocarcinoma With Vascular Involvement Shows Promise
    Massoumi, Roxanne L.
    Hines, O. Joe
    [J]. JAMA SURGERY, 2019, 154 (10) : 942 - 942
  • [49] Evaluating the caregiver experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma
    Ruff, Samantha M.
    Stevens, Lena
    Bressler, Luke
    Khatri, Rakhsha
    Sarna, Angela
    Ejaz, Aslam M.
    Dillhoff, Mary
    Pawlik, Timothy M.
    Rose, Karen
    Cloyd, Jordan M.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2024, 129 (04) : 775 - 784
  • [50] Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?
    Wang, Chenqi
    Tan, Guang
    Zhang, Jie
    Fan, Bin
    Chen, Yunlong
    Chen, Dan
    Yang, Lili
    Chen, Xiang
    Duan, Qingzhu
    Maimaiti, Feiliyan
    Du, Jian
    Lin, Zhikun
    Gu, Jiangning
    Luo, Haifeng
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
12345